Yezan Munther Haddadin's Net Worth

-$64.4 Thousand

Estimate Recalculated Sep 8, 2024 07:37PM EST

Who is Yezan Munther Haddadin?

Yezan Munther Haddadin does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Outlook Therapeutics, Inc..

SEC CIK

Yezan Munther Haddadin's CIK is 0001718004

Past Insider Trading and Trends

2020 was Yezan Munther Haddadin's most active year for acquiring shares with 6 total transactions. Yezan Munther Haddadin's most active month to acquire stocks was the month of September. 2020 saw Yezan Munther Haddadin paying a total of $95,636.77 for 616,826 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Outlook Therapeutics, Inc. (OTLK) Snapshot price: $7.95

Investor

Yezan Munther Haddadin owns 5,048.711 units of Common Stock which is worth $40,137.25. From 2018 to 2024 Yezan Munther Haddadin acquired a total of 65,224.711 shares in Outlook Therapeutics, Inc. at a cost of $104,527.30.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+59.42%
1.88K
$11.82
$22,241.83
5.05K
Mar 28
Form 4
—
0
—
—
0
Mar 7
Form 4
—
0
—
—
0
Oct 4
Form 4
—
0
—
—
0
Mar 29
Form 4
+111.14%
33.34K
$1.29
$42,940.47
63.34K
Oct 6 - Oct 7
Form 4
—
0
—
—
0
Oct 5
Form 4
—
0
—
—
0
Mar 23
Form 4
+50.00%
10K
$1.39
$13,900.00
30K
Dec 2
Form 4
—
0
—
—
0
Oct 5
Form 4
+100.00%
10K
$1.82
$18,200.00
20K
Apr 19
Form 4
—
0
—
—
0
Mar 24
Form 4
—
0
—
—
0
Oct 1 - Oct 5
Form 4
∞
10K
$0.72
$7,245.00
10K
Sep 22
Form 4
—
0
—
—
0
Jul 17
Form 4
—
0
—
—
0
Mar 19
Form 4
—
0
—
—
0
Jan 2
Form 4
—
0
—
—
0
Oct 3
Form 3
—
0
—
—
0
Form 4
—
0
—
—
0
Oct 31
Form 3
—
0
—
—
0
No matching records found